Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Seryl-tRNA Synthetase (SARS) (AA 2-233) anticorps (FITC)

Cet anticorps anti- est un anticorps Lapin Polyclonal détectant dans WB, ELISA et IHC. Adapté pour Humain.
N° du produit ABIN1046073

Aperçu rapide pour Seryl-tRNA Synthetase (SARS) (AA 2-233) anticorps (FITC) (ABIN1046073)

Antigène

Voir toutes Seryl-tRNA Synthetase (SARS) Anticorps
Seryl-tRNA Synthetase (SARS)

Reactivité

  • 28
  • 15
  • 15
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Humain

Hôte

  • 26
  • 2
Lapin

Clonalité

  • 27
  • 1
Polyclonal

Conjugué

  • 18
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
FITC

Application

  • 18
  • 9
  • 7
  • 5
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Épitope

    • 4
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    AA 2-233

    Fonction

    SARS Antibody, FITC conjugated

    Purification

    Protein G purified

    Pureté

    >95 %

    Immunogène

    Recombinant Human Serine--tRNA ligase, cytoplasmic protein (2-233AA)

    Isotype

    IgG
  • Indications d'application

    Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid freeze and thaw cycles. Product is photosensitive and should be protected from light.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    Seryl-tRNA Synthetase (SARS)

    Autre désignation

    SARS

    Sujet

    Background: Catalyzes the attachment of serine to tRNA(Ser) in a two-step reaction: serine is first activated by ATP to form Ser-AMP and then transferred to the acceptor end of tRNA(Ser) (PubMed:22353712, PubMed:24095058, PubMed:9431993, PubMed:26433229, PubMed:28236339). Is probably also able to aminoacylate tRNA(Sec) with serine, to form the misacylated tRNA L-seryl-tRNA(Sec), which will be further converted into selenocysteinyl-tRNA(Sec) (PubMed:9431993, PubMed:26433229, PubMed:28236339). In the nucleus, binds to the VEGFA core promoter and prevents MYC binding and transcriptional activation by MYC (PubMed:24940000). Recruits SIRT2 to the VEGFA promoter, promoting deacetylation of histone H4 at \\\'Lys-16\\\' (H4K16). Thereby, inhibits the production of VEGFA and sprouting angiogenesis mediated by VEGFA (PubMed:19423848, PubMed:19423847, PubMed:24940000).

    Aliases: C78314 antibody, cytoplasmic antibody, EC 6.1.1.11 antibody, FLJ36399 antibody, sarS antibody, Sars1 antibody, Serine tRNA ligase 1, cytoplasmic antibody, Serine tRNA ligase antibody, Serine--tRNA ligase antibody, serine--tRNA ligase, cytoplasmic antibody, SerRS antibody, SERS antibody, Seryl tRNA Ser/Sec synthetase antibody, Seryl tRNA synthetase antibody, Seryl tRNA synthetase cytoplasmic antibody, Seryl-tRNA Ser/Sec synthetase antibody, Seryl-tRNA synthetase antibody, seryl-tRNA synthetase, cytoplasmic antibody, Seryl-tRNA(Ser/Sec) synthetase antibody, Strs antibody, SYSC_HUMAN antibody

    UniProt

    P49591
Vous êtes ici:
Chat with us!